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Introduction
Mechanisms controlling embryologic development of fetal pituitary tissue may provide important insights into the differentiation of pituitary function. Cells of the anterior pituitary express highly differentiated trophic hormone gene products, and their cytogenesis from a common pituitary stem cell involves complex nuclear and membrane signaling systems, resulting in spe-cific cell types secreting either growth hormone (GH),' prolactin (PRL), adrenocorticotropin (ACTH), thyroid-stimulating hormone (TSH), and gonadotropin (follicle-stimulating hormone [FSH] and luteinizing hormone [LH] ) hormones (1) . Each of these trophic hormones is under stimulatory or inhibitory mediation by unique hypothalamic hormones that bind to specific pituitary cell surface receptors (2) .
Specific pituitary cell types are also regulated by intrapituitary cytokines and growth factors that mediate cell growth or local regulation of angiogenesis. The pituitary is an abundant source of several growth factors, including basic fibroblast growth factor, which modulates PRL and TSH release in vitro (3, 4) . Epidermal growth factor modulates pituitary secretion in vitro (5) (6) (7) , and transforming growth factor-a is expressed by pituitary lactotrophs (8) . Insulin-like growth factor I is expressed and regulated in somatotrophs and has been recognized as a mediator of GH synthesis (9, 10) . Interleukins 1 and 6 have also been detected in rat and human pituitary tissue ( 11) , and these cytokines have been shown to regulate the corticotropin-releasing hormone (CRH) -ACTH axis in vitro (12) and in vivo (13).
Since growth and differentiation of hormone-secreting and non-hormone-secreting pituitary cells may be mediated by paracrine regulators of angiogenesis and endothelial cell growth (14) , we investigated whether the physiological development of the human pituitary is associated with expression of leukemia inhibitory factor (LIF) . LIF, originally isolated as an inhibitor of mouse Ml myeloid leukemia cells ( 15), stimulates proliferation of hematopoietic progenitor cells, maintains the developmental potential of embryonic stem cells by suppressing differentiation, modulates several differentiated cell functions, and promotes differentiation of cholinergic neurons ( 16) . LIF and oncostatin M (OSM) share 25% amino acid homology (17, 18) , activate a common gpl30 receptor subunit (19), and are produced by a variety of cell types, including bone marrow stromal cells, thymic epithelial cells, fibroblasts, and a number of malignancies (17) .
LIF has been shown to be secreted by cultured bovine pituitary follicular cells and to regulate bovine vascular systems (20) . We therefore investigated the expression of LIF in human fetal and adult pituitary and tested the action of LIF on pituitary function. The results show that the LIF gene is expressed in the developing human fetal pituitary and in both normal and tumorous adult pituitary tissue. Using AtT-20 murine corticotroph cells, LIF and OSM were also shown to stimulate proopio-melanocortin (POMC) mRNA and basal and CRH-induced ACTH secretion. These LIF actions as well as endogenous ACTH secretion are blocked by immunoneutralizing anti-LIF antiserum. The results indicate an intrapituitary autocrine or paracrine mediation of the CRH-ACTH axis by LIF.
Methods
Human fetal pituitary tissue. The use of human fetal tissue followed guidelines outlined by the National Advisory Board on Ethics in Reproduction (21) . Tissues were derived from third party referrals for therapeutic termination to an independent facility with no direct or indirect participation of the investigators in the termination decision. Written informed consent was subsequently obtained by the facility for anonymous distribution of aseptic tissue specimens.
RNA extraction and ribonuclease protection assay. Fetal tissue or AtT-20 cells were used for RNA extraction and subsequent ribonuclease protection assay (22) . Tissues were harvested within several minutes and kept at -70°C. Total tissue RNA was extracted after homogenization by RNA STAT-60 (TEL-TEST' B", Inc., Friendswood, TX). RNA concentrations were estimated by ultraviolet spectrophotometry at 260 nm and 260/280 ratio. Aliquots of RNA samples were electrophoresed through 1% agarose/6.9% formaldehyde gels, and RNA integrity was confirmed by visualization with ethidium bromide.
The BamHI-HindIII fragment of the human LIF cDNA clone or the EcoRI-Xbal fragment of the murine LIF cDNA (23) probes. pTRl-/3-actin, human or murine antisense (Ambion, Austin, TX), was used as an internal standard. The resulting constructs were linearized with NotI (human), HindIll (mucine), gel purified, and subsequently used to generate a LIF antisense probe. The probe labeling was performed using [a-32P]UTP (Du Pont-New England Nuclear, Boston, MA) and in vitro transcription kits (Maxiscript T3/T7, Ambion), followed by gel purification of the riboprobe in a 5% urea/acrylamide gel. T7 RNA polymerase was used for both LIF and 8-actin (human), and T3 RNA polymerase was used for both LIF and /8-actin (murine). The labeled probes were eluted overnight at 37°C in a gel elution buffer containing 2 M ammonium acetate, I % SDS, and 25 ,ug/ml transfer RNA, with shaking. The probes for LIF and /3-actin were each precipitated with 20 ,ug of human tissue RNA extract, 100% ethanol, and 5 M ammonium acetate. The assay was performed using a ribonuclease protection assay (RPA 2 kit, Ambion), following the manufacturer's instructions. Reaction products were redissolved in 20 PI of 80% (vol/ vol) formamide hybridization buffer. Each test sample contained 100,000 cpm, and incubations were for 21 h at 42°C. 20 ,ug of total CEM (human T cell line) RNA was used as a tissue specificity control. Nonhybridized RNA was digested with RNase for I h at 37°C. After redissolving in 8 ,ul of gel loading buffer, denaturation was performed at 95°C for 3 min, and then a 5% urea/acrylamide gel (1500 V) was used for a 3-h separation. The hybridization was visualized by exposure to x-ray film (Fuji, Kanagawa, Japan) for 48 h at -80°C. The level of the /3-actin expression was used as an internal standard to correct for RNA loading. As negative and positive human tissue controls, fetal liver, spleen, intestine, and heart muscle RNAs were also tested. Murine embryonic fibroblasts (STO cells) were used as positive murine cell controls.
Primar)y fetal pituitary cell culture and cell separation. Specimens were harvested in low glucose DME supplemented with 0.3% BSA, 2 mM glutamine, and antibiotics. The pituitary was dissected under a stereomicroscope, and one-half of the tissue was washed carefully, minced with a sterile surgical scalpel, and enzymically dissociated using 0.035% collagenase and 0.0 1% hyaluronidase (both from Sigma Chemical Co., St. Louis, MO). Cell suspensions were filtered and resuspended in low glucose DME supplemented with 2.5% FCS, 2 mM glutamine, and antibiotics after washing. (30) . Tissue from four normal pituitaries was obtained at autopsy from patients dying of multiple myeloma, myocardial infarction, non-Hodgkin's lymphoma, and primary pulmonary arterial hypertension. Sections from pituitary neoplasms were obtained from the surgical pathology files of Cedars-Sinai Medical Center and included eight nonfunctioning adenomas, one prolactinoma, two ACTH-producing adenomas, and four GH-producing adenomas. Sections were deparaffinized and incubated with 3% hydrogen peroxide for 5 min to block endogenous peroxidase activity before immunostaining using methods previously described.
Culture of cells. AtT-20 cells were routinely maintained in Ham's F-10 medium (Gibco BRL, Grand Island, NY) supplemented with 15% horse serum and 2.5% FCS (31). Before test incubations, cells were serum starved for 16 h. Cells were transferred to fresh serumfree DME at a density of 50,000-100,000 cells per ml in microfuge tubes and recombinant human LIF (R & D Systems), OSM (R & D Systems), and CRH (ovine tyr-corticotropin-releasing hormone; Sigma Chemical Co.) were applied at appropriate concentrations in 10 Al of serum-free medium. An equal volume of medium alone was applied to control tubes. After test incubations, cells were pelleted by centrifugation, and the supematant was stored (-20°C) for later ACTH assay using a two-site kit (Nichols Institute). All test incubations were performed in triplicate and assayed in duplicate. Values are expressed as mean±SEM, and statistical significance was assessed by unpaired t test.
Northern analysis ofAtT-20 mRNA. AtT-20 cells (-7 x 106 cells per group) were preincubated for 16 h in serum-free DME and then incubated for an additional 24 h in fresh serum-free DME with or without added treatments. Total cell RNA was extracted using TRIzol Total RNA Isolation Reagent (Gibco, Gaithersburg, MD). Cell pellets obtained by centrifugation were lysed in TRIzol Reagent, and total RNA was isolated by adding chloroform and centrifuging (32). Isolated RNA was precipitated using isopropanol. The RNA pellet was washed using 75% ethanol, denatured in 2.2 M formaldehyde plus 44 mM Mops, pH 7.0, containing 50% deionized formamide, 10 mM sodium acetate, 1 mM EDTA, and 0.25 mM ethidium bromide at 55°C for 15 min, separated by electrophoresis on a 1.2% agarose gel containing 0.37 M formaldehyde and 44 mM Mops at 100 V for 3 h, and transferred to nylon membrane in transfer buffer containing 3 M sodium chlorate and 0.3 M sodium citrate, pH 7.0, at room temperature overnight. The membrane was baked at 80°C for 2 h washed in distilled deionized water, prehybridized in 10 ml of hybridization solution (QuikHyb Rapid, Stratagene) at 68°C for 30 min, and hybridized with _ 106 cpm 32P-labeled murine POMC cDNA at 68°C overnight. Prehybridization and hybridization were performed in a ISS Hybridization oven (Enprotech, Natick, MA). After hybridization, the membrane was washed twice at room temperature for 15 min each in 2x SSC, 0.1% SDS and twice in 0.lx SSC, 0.1% SDS, followed by air drying and autoradiography.
Murine POMC cDNA, kindly provided by Dr. Malcolm J. Low (Portland, OR) (33) , was propagated in DH5-a-competent cells (Gibco) and separated using Qiagen-tip 2500 (QIAGEN Inc., Chatsworth, CA). A 0.6-kb fragment, spanning the 3' half of exon Fig. 4 (Fig. 4 B) .
Hormonze secretion by sorted hiwnatn fetal pituitarY cells.
Pituitary hormones were measured in media from cultures of unsorted cells obtained at 19, 20. and 27 wk gestation, and in vitro hormone levels were also measured after cell sorting and subsequent culture (Table II) . Hormone concentrations increased in a time-dependent manner in the presorted cell cultures. ACTH, FSH, LH, and GH were all detected in presorted cells derived at 19 wk gestation, whereas PRL and TSH were detected, albeit at very low levels, at 20 wk. After sorting, cultures of LIF-R-positive cells, presumably reflecting cultured human pituicytes containing LIF-binding sites, secreted significant levels of ACTH. In contrast, the other anterior pituitary hormones were undetectable in these cultures derived from LIF-R-positive cells at 19, 20, and 27 wk gestation.
LIF immunostainin1g in niormal adult pituitaries and pituitarv adenomnas. To determine the adult expression of pituitary LIF, normal pituitary tissue sections as well as 15 pituitary adenomas were immunostained for LIF (Table III) . Four normal pituitaries stained strongly for LIF (Table III) , whereas variable staining occurred in pituitary adenomas. Strong (two cases) and intermediate (two cases) staining was present in GH-producing adenomas, and intermediate staining was also observed in two ACTH-producing adenomas. Negligible LIF staining (trace to weak) was present in eight nonfunctioning adenomas and one prolactinoma.
LIF action oni cullturedfetal pituitary inonolavers. To study the effects of exogenous LIF on human fetal ACTH secretion, cells ( 16 wk gestation) were seeded, and after 24 h, incubations continued in serum-free defined medium with added LIF. ACTH levels were almost doubled by LIF (50 ng/ml), whereas no significant change in concentrations of the other pituitary hormones was detected. Because of the difficulty in obtaining larger numbers of human fetal tissue specimens, as well as the technical problems inherent in primary cultures of hormone-secreting human fetal tissue, subsequent in vitro experiments were performed using the AtT-20 murine corticotroph cell line.
LIF regulationi of POMC genie expression anzd ACTH secretioni. As AtT-20 cells also expressed LIF and contained LIFbinding sites, they were considered a relevant model for studying in vitro pituitary LIF action on POMC gene expression.
AtT-20 cells were exposed to LIF in serum-free conditions for up to 24 h, and POMC mRNA levels were measured. Basal POMC expression was high, and mRNA levels were readily measurable when only 8 pg of total RNA was subjected to hybridization (Fig. 5) . Both LIF and OSM induced the levels of POMC mRNA after an 8-h incubation (Fig. 6 ). LIF (100 or 1,000 pM) induced the levels of POMC transcripts by over 50%, and 1 nM OSM similarly stimulated POMC mRNA. ACTH secretion by AtT-20 cells was stimulated by both LWF and OSM (Fig. 7) . This effect was detectable within 6 h of exposure to the cytokine and persisted for at least 72 h. The ED50 values for LIF and OSM were 10 and 30 pM, respectively. Significant stimulation of ACTH was observed with 1 pM LIF (P = 0.027) and 10 pM OSM (P = 0.045), and the maximal stimulation, achieved at a concentration of 300 pM at 24 h, was 60-80% above basal ACTH secretion for both cytokines. When the cytokines were applied in combination, at concentrations that, individually, elicited maximal stimulation of ACTH secretion (1 nM), no further stimulation of ACTH secretion was observed (Fig. 8) .
CRH, as expected, was a potent stimulator of ACTH secretion, increasing secretion up to threefold during 24-h incubations. Coincubation of AtT-20 cells with CRH and either LIF or OSM resulted in a significant (P < 0.001) potentiation of ACTH secretion: compared with cells exposed to CRH alone, the addition of LIF or OSM resulted in a two-to threefold enhancement of the ACTH response to CRH (Fig. 8) . Exposure to CRH together with maximal doses of LIF and OSM together did not significantly increase ACTH concentrations, compared with CRH and LIF or CRH and OSM, respectively.
To confirm the relevance of endogenously produced LIF in regulation of ACTH secretion, experiments were performed in the presence of specific anti-LIF antiserum or nonimmune sera. As shown in Fig. 9 Adenohypophyseal cells appear to arise from an early stem cell that subsequently undergoes differentiation and compartmentalized commitment to express the specific anterior pituitary trophic hormones (1). Cell-specific transcription factors for GH, PRL, and TSH have been described (1) . Although murine models for cell-specific development of POMC expression (33) have recently been developed, little information is available on the ontogeny of the human corticotroph cell. In the rat, expression of ACTH precedes that of other trophic hormones (1). In the human, immunoreactive ACTH is detected in Rathke's pouch by week 5 (34, 35) , before development of a mature human hypophyseal-portal vascular system, which occurs between the 8th and 14th week. At 14 wk, the fetal corticotroph is sensitive to CRH stimulation (36) . These observations imply that factors other than hypothalamic CRH are involved in determining the cell-specific expression of the early fetal corticotroph. Dramatically increased intensity of ACTH-immunoreactive pituitary cells occurs through the end of the second trimester. In the rat, increased corticotroph proliferation occurs in response to CRH (37) , and the mature adult pituitary cell population consists of 10-20% corticotrophs (35 (39, 40) . Using a 600-bp radiolabeled human cRNA excluding the first exon, the 400-bp protected human pituitary LIF mRNA detected in fetal pituitary tissue is consistent with divergent splicing of the human LIF gene, as has been suggested for the murine LIF gene (41) . In murine embryonic stem cells, altemative LIF transcripts are independently expressed and may give rise to either a diffusible or matrix-associated form of the protein (40) . The three protected mRNA bands detected in AtT-20 cells are similar in size to the previously reported three murine embryonic cell LIF transcripts (40) . Whether the 400-bp protected transcript detected in human fetal tissue reflects a similar functional splicing distinction is unclear and requires further study.
FACS sorting revealed that both human fetal pituitary cells and AtT-20 corticotroph cells express surface sites that bind biotinylated LIF. This binding was displaceable by excess unlabeled LIF ligand. The use of antibodies against CD series antigens enabled clear distinction of the relatively small population of macrophage or monocytic cells that may have been infiltrating the pituitary, thus allowing isolation of a population of endogenous human fetal pituicytes expressing LIF surface binding markers. Furthermore, using biotinylated LIF, immunoreactive LIF-binding sites were also detected by immunochemistry in both hormone-secreting and non-hormone-secreting fetal pituitary cells. ACTH-secreting cells appear to account for the majority of secretory fetal pituitary cells cultured after sorting for LIF-R, and using costaining techniques, ACTH coexpression was detected in about one-third of LIF-and LIF-R-immunoreactive cells. Nevertheless, the relative sensitivities of the pituitary trophic hormone assays may have precluded earlier detection of non-ACTH hormones, especially GH, in the LIF-Rpositive pituitary cultures.
Several cytokines are known to interact with the hypothalamo-pituitary axis, modulating the output of pituitary hormones (11) , and several of these are expressed in the rat and human pituitary. In human pituitary tumors, IL-2, IL-2 receptor, and IL-6 have been shown to be expressed by either immunostaining, in situ hybridization, or direct in vitro assay (42- TlOTAL RNA (ug) 8 16 25 stress response. CRH release is induced by IL-l and IL-6 (12); although IL-l and IL-6 also stimulate rat and murine ACTH release and POMC mRNA levels (51, 52) , the evidence for a direct pituitary role of IL-l has been conflicting (12) . LIF and OSM are two members of a recently defined family of structurally and functionally related cytokines that include IL-6, IL-l 1, and ciliary neurotrophic factor ( 17 ) . Although LIF and its receptor differ in structure from IL-6 and its receptor, they share a common gpl3O receptor subunit (19). Signaling by the LIF receptor follows a 1:1 heterodimerization of the gpl3O subunit with the high affinity LIF receptor /3 subunit, resulting in a high affinity LIF-binding site (53) . In contrast, IL-6 signaling involves homodimerization of gpl3O with a low affinity IL-6-binding protein (54) . OSM and LIF share a number of structural and functional similarities (19), and OSM binds to the high affinity (but not the low affinity) LIF (16) , and blocks aortic endothelial cell proliferation (20) . OSM also possesses growth-inhibiting activity (17) . Recently, IL-6 and IL-2 have been shown to inhibit [3H] thymidine incorporation into adult rat pituitary cells (58) . These cytokines may therefore regulate pituitary mitotic activity in addition to their effects on hormone secretion.
Although LIF, OSM, and to a lesser extent IL-6 and granulocyte colony-stimulating factor share some similar functions, their divergent amino acid sequences suggest that they also possess unique nonredundant functions ( 18 ). For example, inhibition of stem cell differentiation (54) and regulation of cholinergic neurons (59) (13, 60, 61) . Elevated circulating levels of LIF have alone.
been described in certain inflammatory disease states, such as giant cell arteritis (60) and septic shock (61) , and it has been proposed that circulating or locally produced cytokines may influence pituitary function during systemic stress (13). Pituitary cytokine interactions may occur independently of CRH (62) , and autocrine or paracrine modulation of ACTH secretion independent of changes in CRH may also occur during systemic stress (63) . Nevertheless, the factors controlling LIF expression and action within the pituitary are not yet known. Overexpression of murine LIF causes a fatal early cachexia. These ill mice show evidence of multiple organ damage as well as adrenal atrophy (64) . Whether the loss of adrenal lipid is due primarily to LIF or to the effects of severe cachexia is difficult to determine. LIF knockout mice exhibit retarded growth and suppression of hematopoietic stem cells, and females characteristically are unable to implant a fertilized ovum successfully (65), suggesting that uterine LIF facilitates blastocyst implantation. Endometrial and pituitary LIF expression and function may therefore be important effectors of the immune-endocrine interface. Furthermore, LIF has been suggested to regulate development of pituitary angiogenesis (20) and is here shown to be expressed in both fetal and adenomatous pituitary tissue. It may therefore play a role in pituitary embryogenesis as well as tumorigenesis.
Evidence for an intrapituitary paracrine or autocrine regulatory mechanism for corticotroph development and function presented in these studies suggests the presence of a novel autocrine or paracrine LIF-ACTH regulation that may be a determinant of differentiated corticotroph cell development and function.
